close Icon

Research Articles

Explore our library of peer-reviewed publications below, with contributions from Burnet researchers.

See also: Research Reports + Policy Briefs

Form Loading Icon
Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA.

Banister SD, Adams A, Kevin RC, Macdonald C, Glass M, Boyd R, Connor M, McGregor IS, Havel CM, Bright SJ, Vilamala MV, Lladanosa CG, Barratt MJ, Gerona RR

Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA.
Antimetastatic effect of the pharmacological inhibition of serine/arginine-rich protein kinases (SRPK) in murine melanoma.

Moreira GA, Lima GDA, Siqueira RPS, Barros MVDA, Adjanohoun ALM, Santos VC, Barbosa EAA, Loterio RK, Paiva JC, Gonçalves VHS, Viol LCS, Marques-da-Silva EA, Silva Júnior A, Almeida MR, Fietto JLR, Machado-Neves M, Ferreira RS, Teixeira RRT, Bressan GCB

Antimetastatic effect of the pharmacological inhibition of serine/arginine-rich protein kinases (SRPK) in murine melanoma.
Cohort Profile: The Flu Watch Study.

Fragaszy EB, Warren-Gash C, Wang L, Copas A, Dukes O, Edmunds WJ, Goonetilleke N, Harvey G, Johnson AM, Kovar J, Lim MS, McMichael A, Millett ER, Nazareth I, Nguyen-Van-Tam JS, Tabassum F, Watson JM, Wurie F, Zambon M, Hayward AC, Flu Watch Group

Cohort Profile: The Flu Watch Study.
Epidemiology and associated risk factors of giardiasis in a peri-urban setting in New South Wales Australia.

Zajaczkowski P, Mazumdar S, Conaty S, Ellis JT, Fletcher-Lartey SM

Epidemiology and associated risk factors of giardiasis in a peri-urban setting in New South Wales Australia.
Molecular dissection of an inhibitor targeting the HIV integrase dependent preintegration complex nuclear import.

Wagstaff KM, Headey S, Telwatte S, Tyssen D, Hearps AC, Thomas DR, Tachedjian G, Jans DA

Molecular dissection of an inhibitor targeting the HIV integrase dependent preintegration complex nuclear import.
Aiming for the elimination of viral hepatitis in Australia, New Zealand, and the Pacific Islands and Territories: Where are we now and barriers to meeting World Health Organization targets by 2030.

Howell J, Pedrana A, Cowie BC, Doyle J, Getahun A, Ward J, Gane E, Cunningham C, Wallace J, Lee A, Malani J, Thompson A, Hellard ME

Aiming for the elimination of viral hepatitis in Australia, New Zealand, and the Pacific Islands and Territories: Where are we now and barriers to meeting World Health Organization targets by 2030.